Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427737 · ClinicalTrials.gov registry record · NA
Comfort Talk and Economic Outcomes in MRI
A NA study of Claustrophobia and Complication of Diagnostic Procedure, sponsored by Hypnalgesics.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 3
- Study locations
NCT02427737: Completed NA study of Claustrophobia and Complication of Diagnostic Procedure, sponsored by Hypnalgesics.
NCT02427737 is a NA study of Claustrophobia and Complication of Diagnostic Procedure that has completed, run by Hypnalgesics. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02427737, a NA study of Claustrophobia and Complication of Diagnostic Procedure, has completed, sponsored by Hypnalgesics.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 3
- Study locations
Study Summary
Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staffs working in MRI facilities to provide Comfort Talk® will enable patients to complete high quality imaging without medication, which will increase satisfaction and comfort while reducing sedation risks for patients, and increase efficiency and reduce loss of revenue for facilities. The effect of such training will be tested at 12 MRI sites in a randomized design. Outcome data will be collected for one year.
Primary Outcome
Quarterly completion rate of MRIs as a proportion of scans completed per given number of imaging slots available
Conditions Studied
Interventions
- BEHAVIORAL Comfort Talk® Training
Study Locations (3)
Massachusetts
- Hypnalgesics, LLC - Brookline
North Carolina
- Duke University Medical Center - Durham
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-07-31 |
| Phase | NA |
What the finished NCT02427737 record still lists
NCT02427737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Claustrophobia appearing as the primary indexed condition, and to 1 intervention - of which Comfort Talk® Training is the first listed.
NCT02427737 reports a single indexed study location in Massachusetts, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT02427737 about?
NCT02427737 is a clinical study titled "Comfort Talk and Economic Outcomes in MRI". Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staffs working in MRI facilities to provide Comfort Talk® will enable patients to complete high quality imaging without medication, which will increase sat...
What is the current status of trial NCT02427737?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2017-07-31.
What conditions does trial NCT02427737 study?
This clinical trial studies the following conditions: Claustrophobia, Complication of Diagnostic Procedure.
What interventions are being tested in trial NCT02427737?
The interventions under investigation include: Comfort Talk® Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02427737?
This trial is sponsored by Hypnalgesics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02427737 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Claustrophobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02427737's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia